Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate

被引：0
|
作者：
R. A. Wermers
C. P. Recknor
F. Cosman
L. Xie
E. V. Glass
J. H. Krege
机构：
[1] Mayo Clinic,Division of Endocrinology and Metabolism
[2] United Osteoporosis Centers,Clinical Research Center
[3] Helen Hayes Hospital,Eli Lilly and Company
[4] Lilly Corporate Center,undefined
来源：
Osteoporosis International | 2008年 / 19卷
关键词：
Alendronate; Hypercalcemia; Postmenopausal osteoporosis; Raloxifene; Serum calcium; Teriparatide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1055 / 1065
页数：10
相关论文
共 50 条
  • [31] Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
    Gamsjaeger, Sonja
    Buchinger, Birgit
    Zoehrer, Ruth
    Phipps, Roger
    Klaushofer, Klaus
    Paschalis, Eleftherios P.
    BONE, 2011, 49 (06) : 1160 - 1165
  • [32] Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis
    Johnell, O
    Scheele, WH
    Lu, YL
    Reginster, JY
    Need, AG
    Seeman, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03): : 985 - 992
  • [33] Bone marker variations in postmenopausal women with osteoporosis treated with teriparatide
    Barata, S.
    Osorio, F.
    Pauleta, J.
    Santo, S.
    Neves, J.
    Pereira-Coelho, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S342 - S342
  • [34] Effects of teriparatide on quality of life in postmenopausal women with osteoporosis
    Rosa, Jan
    Kasalicky, Petr
    Mala, Ivana
    BONE, 2008, 42 : S85 - S86
  • [35] Raloxifene in combination with teriparatide reduces teriparatide-induced stimulation of bone resorption but not formation in postmenopausal women with osteoporosis
    Deal, C
    Omizo, M
    Schwartz, EN
    Eriksen, EF
    Cantor, P
    Wang, J
    Glass, EV
    Myers, SL
    Krege, JH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S44 - S44
  • [36] REDUCTION IN BACK PAIN FOLLOWING TERIPARATIDE COMPARED WITH ALENDRONATE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Dore, R. K.
    Krege, J. H.
    Chen, P.
    Glass, E. V.
    Martin, J. San
    Miller, P. D.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S89 - S89
  • [37] iPTH levels in postmenopausal women with osteoporosis treated with alendronate.
    Massari, F
    Zanchetta, JR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S470 - S470
  • [38] Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial
    Bonnick, Sydney
    De Villiers, Tobias
    Odio, Alberto
    Palacios, Santiago
    Chapurlat, Roland
    DaSilva, Carolyn
    Scott, Boyd B.
    De Tilleghem, Celine Le Bailly
    Leung, Albert T.
    Gurner, Deborah
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4727 - 4735
  • [39] DIFFERENCES IN EARLY DYNAMICS OF SERUM BONE MARKERS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED BY ALENDRONATE OR RISEDRONATE
    Sferrazza, C.
    Carmina, E.
    Cannone, V.
    Avila, D.
    Sutera, L.
    Rini, G. B.
    Di Fede, G.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S97 - S97
  • [40] Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosis treated by alendronate or risedronate
    Sferrazza, C
    Napoli, N
    Cannone, V
    Cusumano, G
    Rini, G
    Di Fede, G
    BONE, 2005, 36 : S422 - S423
12345